Phibro Animal Health Corp (OQ:PAHC)

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEC
Company Contact
Address: 300 Frank W. Burr Blvd.
Suite 21, 65 Challenger Road
TEANECK NJ 07666
Tel: N/A
Website: https://www.pahc.com
IR: See website
<
Key People
Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Glenn C. David
Chief Financial Officer
Jonathan Bendheim
Director, President of MACIE Region and General Manager of Israel Operations
Rob Aukerman
President, North America Region
Larry Lee Miller
Chief Operating Officer
Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Lisa A. Escudero
Senior Vice President - Human Resources
Anthony Andolino
Vice President - Finance, Treasurer
Business Overview
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.
Financial Overview
For the six months ended 31 December 2023, Phibro Animal Health Corp revenues increased 1% to $481.3M. Net loss totaled $6.7M vs. income of $11.1M. Revenues reflect Animal Health segment increase of 5% to $333.6M, Latin America and Canada segment increase of 17% to $123.9M, Asia Pacific segment increase of 2% to $29.2M. Net loss reflects Foreign currency (gains) losses, net increase from $5.1M to $14.2M (expense).
Employees: 1,920 as of Jun 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $906.12M as of Dec 31, 2023
Annual revenue (TTM): $982.01M as of Dec 31, 2023
EBITDA (TTM): $107.65M as of Dec 31, 2023
Net annual income (TTM): $14.80M as of Dec 31, 2023
Free cash flow (TTM): $17.58M as of Dec 31, 2023
Net Debt Last Fiscal Year: $382.41M as of Dec 31, 2023
Shares outstanding: 40,503,608 as of Feb 2, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.